Table 1.
Demographic Data of Patients Used in This Study
| Sample no. | Classification | Age (yr)/Sex | Specimen type | Tissue diagnosis |
|---|---|---|---|---|
| 1 | Normal | 70/F | Lobectomy | Adenocarcinoma |
| 2 | Normal | 81/M | Lobectomy | NSCLC |
| 3 | Normal | 65/M | Lobectomy | SCC |
| 4 | Normal | 69/F | Lobectomy | NSCLC |
| 5 | Normal | 66/F | Lobectomy | Adenocarcinoma |
| 6 | Normal | 66/F | Lobectomy | Adenocarcinoma |
| 7 | Normal | 70/F | Lobectomy | NSCLC |
| 8 | IPF | 53/F | Explant | IPF |
| 9 | IPF | 59/F | Explant | IPF |
| 10 | IPF | 68/M | Biopsy | IPF |
| 11 | IPF | 53/F | Explant | IPF |
| 12 | IPF | 59/F | Explant | IPF |
| 13 | IPF | 68/M | Biopsy | IPF |
| 14 | IPF | 43/F | Explant | IPF |
| 15 | IPF | 61/M | Biopsy | IPF |
| 16 | IPF | 58/M | Biopsy | IPF |
| 17 | IPF | 61/F | Explant | IPF |
Samples 1 to 7 are from pathologically normal tissue taken from surgical lobectomies of lung cancer patients. Samples 8 to 10 are derived from microdissected fibroblastic foci taken from samples 11 to 13. Samples 11 to 17 are homogenates of grossly abnormal lung, selected for abundance of fibroblastic foci. NSLC, non-small cell lung carcinoma; SCC, Small cell lung carcinoma.